Hormone replacement therapy and risk of meningioma in women: A meta-analysis

Cancer Causes and Control

Volumn 24, Issue 8, 2013, Pages 1517-1525

  Fan, Zuo Xu ^a   Shen, Jian ^a   Wu, Yao Yao ^b   Yu, Hai ^a   Zhu, Yu ^a   Zhan, Ren Ya ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b People's Liberation Army 117 Hospital   (China)

Author keywords

Hormone replacement therapy; Meningioma; Meta analysis; Risk factor

Indexed keywords

HORMONE;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MENINGIOMA; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS;

CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; RISK FACTORS;

EID: 84880326620     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0228-7     Document Type: Article

References (41)

1. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57(6):1088-1095
2. Bondy M, Ligon BL (1996) Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 29(3):197-205
3. Ragel BT, Jensen RL (2005) Molecular genetics of meningiomas. Neurosurg Focus 19(5):E9
4. Krampla W, Newrkla S, Pfisterer W, et al. (2004) Frequency and risk factors for meningioma in clinically healthy 75-year-old patients. Cancer 100(6):1208-1212
5. Phillips LE, Frankenfeld C, Drangsholt M, Koespell TD, vanBelle G, Longstreth WT (2005) Intracranial meningioma and ionizing radiation in medical and occupational settings. Neurology 64(2):350-352
6. Koper JW, Lamberts SW (1994) Meningiomas, epidermal growth factor and progesterone. Hum Reprod 9(Suppl 1):190-194
7. Custer BS, Koepsell T, Mueller BA (2002) The association of breast carcinoma and meningioma in women. Cancer 94(6):1626-1635
8. Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86(1):113-120
9. Speirs V, Boyle-Walsh E, Fraser WD (1997) Constitutive co-expression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones. Int J Cancer 72(5):714-719
10. Jay JR, MacLaughlin DT, Riley KR, Martuza RL (1985) Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62(5):757-762
11. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99(5):848-853
12. Hatch EE, Linet MS, Zhang J, et al. (2005) Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114(5):797-805
13. Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F (2006) Association of meningioma with reproductive factors. Int J Cancer 119(5):1152-1157
14. Custer B, Longstreth WT Jr, Phillips LE, Koepsell TD, Van Belle G (2006) Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 6:152
15. Wigertz A, Lönn S, Mathiesen T, et al. (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164(7):629-636
16. Blitshteyn S, Crook JE, Jaeckle KA (2008) Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 26(2):279-282
17. Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, Auvinen A (2010) Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control 21(12):2149-2156
18. Benson VS, Pirie K, Green J, et al. (2010) Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int J Cancer 127(7):1692-1698
19. Michaud DS, Gallo V, Schlehofer B, et al. (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European Cohort Study. Cancer Epidemiol Biomarkers Prev 19(10):2562-2569
20. Johnson DR, Olson JE, Vierkant RA, et al. (2011) Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study. Neuro-Oncol 13(9):1011-1019
21. Cea-Soriano L, Blenk T, Wallander MA, Rodríguez LA (2012) Hormonal therapies and meningioma: is there a link? Cancer Epidemiol 36(2):198-205
22. Stroup DF, Berlin JA, Morton SC, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008-2012
23. Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9:1-30
24. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820-826
25. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188
26. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719-748
27. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088-1101
28. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629-634
29. Wigertz A, Lonn S, Hall P, et al. (2008) Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 17(10):2663-2670
30. Schlehofer B, Blettner M, Wahrendorf J (1992) Association between brain tumors and menopausal status. J Natl Cancer Inst 84(17):1346-1349
31. Lambe M, Coogan P, Baron J (1997) Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 72(3):389-393
32. Cantor KP, Lynch CF, Johnson D (1993) Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 4(6):505-511
33. Benson VS, Pirie K, Green J, Casabonne D, Beral V (2008) Lifestyle factors and primary glioma and meningioma tumours in the million women study cohort. Br J Cancer 99(1):185-190
34. Schlehofer B, Blettner M, Preston-Martin S, et al. (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82(2):155-160
35. Korhonen K, Auvinen A, Lyytinen H, Ylikorkala O, Pukkala E (2012) A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland. Am J Epidemiol 175(4):309-314
36. Cowppli-Bony A, Bouvier G, Rué M, et al. (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22(5):697-714
37. Claus EB, Black PM, Bondy ML, et al. (2007) Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 110(3):471-476
38. Bickerstaff ER, Small JM, Guest IA (1958) The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatr 21(2):89-91
39. Michelsen JJ, New PF (1969) Brain tumour and pregnancy. J Neurol Neurosurg Psychiatr 32(4):305-307
40. Gazzeri R, Galarza M, Gazzeri G (2007) Growth of a meningioma in a transsexual patient after estrogen-progestin therapy. N Engl J Med 357(23):2411-2412
41. Deipolyi AR, Han SJ, Parsa AT (2010) Development of a symptomatic intracranial meningioma in a male-to-female transsexual after initiation of hormone therapy. J Clin Neurosci 17(10):1324-1326